| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jurgen J Fütterer | |
| P2860 | cites work | ESUR prostate MR guidelines 2012 | Q24620926 |
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 | ||
| Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges | Q30977250 | ||
| Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy | Q30983669 | ||
| Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference | Q30995961 | ||
| Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data | Q33679272 | ||
| Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-Analysis | Q57253236 | ||
| Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings | Q63966237 | ||
| Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases | Q68948658 | ||
| Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy | Q73164185 | ||
| Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging | Q73617331 | ||
| Analysis of clinicopathologic factors predicting outcome after radical prostatectomy | Q73746374 | ||
| Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? | Q74591846 | ||
| Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules | Q79782306 | ||
| Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer | Q81160853 | ||
| Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis | Q82640665 | ||
| In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil | Q83653486 | ||
| Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer | Q85719899 | ||
| Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter | Q34323096 | ||
| Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness | Q34995967 | ||
| Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. | Q35495406 | ||
| Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications | Q35773547 | ||
| Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy | Q36180862 | ||
| Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers | Q36294626 | ||
| Angiogenesis imaging in the management of prostate cancer | Q36395057 | ||
| Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging | Q36434291 | ||
| Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software. | Q36465803 | ||
| MR imaging in local staging of prostate cancer | Q36906406 | ||
| Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy | Q37007165 | ||
| Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients | Q37009160 | ||
| Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer | Q37866554 | ||
| Prostate cancer: multiparametric MR imaging for detection, localization, and staging. | Q37935483 | ||
| Update on the Gleason grading system | Q37952882 | ||
| Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer | Q38006939 | ||
| Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T. | Q38074934 | ||
| Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. | Q38080001 | ||
| Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. | Q38113308 | ||
| Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient | Q38183063 | ||
| How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? | Q38271250 | ||
| Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature | Q38346015 | ||
| Understanding the pathological implications of MRI: application to focal therapy planning | Q38376682 | ||
| Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology | Q38559175 | ||
| Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. | Q38795460 | ||
| The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? | Q39694955 | ||
| Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies | Q41637241 | ||
| Application of transrectal ultrasound-guided repeat needle biopsy in the diagnosis of prostate cancer in Chinese population: A retrospective study | Q42363869 | ||
| Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. | Q45989559 | ||
| Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. | Q46172434 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | magnetic resonance imaging | Q161238 |
| prostate cancer | Q181257 | ||
| prostate neoplasm | Q56014511 | ||
| P1104 | number of pages | 10 | |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 597-606 | |
| P577 | publication date | 2017-05-19 | |
| P1433 | published in | Korean journal of radiology : official journal of the Korean Radiological Society | Q26842124 |
| P1476 | title | Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer | |
| P478 | volume | 18 |
| Q90101246 | A Deep Learning-Based Approach for the Detection and Localization of Prostate Cancer in T2 Magnetic Resonance Images |
| Q92108212 | A Glimpse on Trends and Characteristics of Recent Articles Published in the Korean Journal of Radiology |
| Q60910241 | Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy |
| Q52665654 | Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection. |
| Q104504831 | The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy |
| Q55385233 | Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB. |
Search more.